GSK gets R&D grant that aims to protect U.K. jobs

Economic development officials in the U.K. appear determined to stem the loss of pharma jobs. Scottish Enterprise has awarded a £1.46 million research and development grant to GlaxoSmithKline ($GSK) to support the London-based drug giant's operations in Montrose. The grant is intended to boost research at the site, support the creation of 25 new jobs and protect existing positions. Release

Suggested Articles

Esperion's Nexletol has had a rough road to approval after safety concerns nearly derailed its quest. But an FDA nod has the drug ready for market.

In an interview with Israel's Calcalist, Teva CEO Kåre Schultz shared details of his approach to the company's turnaround.

Nerlynx is already struggling in its extended adjuvant breast cancer setting, and new entrants from Daiichi-AZ and SeaGen could pressure it elsewhere.